Jaguar Health, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for JAGX, updated each market day.
JAGX AI Sentiment
AI predicts Jaguar Health, Inc. stock is likely to decrease over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Jaguar Health, Inc.
Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
Sector
Exchange
Market Cap
$5,134,802
Cap Tier
Employees
47
Headquarters
SAN FRANCISCO, CA
Listed Since
May 13, 2015
Website
JAGX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
JAGX Volatility
Jaguar Health, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
